- Home
- VTYX vs IH Comparison
VTYX vs IH Comparison
Compare VTYX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- IH
- Stock Information
- Founded
- VTYX 2018
- IH 1996
- Country
- VTYX United States
- IH China
- Employees
- VTYX N/A
- IH N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- IH Other Consumer Services
- Sector
- VTYX Health Care
- IH Real Estate
- Exchange
- VTYX Nasdaq
- IH Nasdaq
- Market Cap
- VTYX 154.9M
- IH 142.2M
- IPO Year
- VTYX 2021
- IH 2020
- Fundamental
- Price
- VTYX $10.38
- IH $2.85
- Analyst Decision
- VTYX Strong Buy
- IH
- Analyst Count
- VTYX 5
- IH 0
- Target Price
- VTYX $14.60
- IH N/A
- AVG Volume (30 Days)
- VTYX 2.5M
- IH 11.4K
- Earning Date
- VTYX 11-06-2025
- IH 12-26-2025
- Dividend Yield
- VTYX N/A
- IH 3.15%
- EPS Growth
- VTYX N/A
- IH N/A
- EPS
- VTYX N/A
- IH 0.29
- Revenue
- VTYX N/A
- IH $123,215,612.00
- Revenue This Year
- VTYX N/A
- IH $39.02
- Revenue Next Year
- VTYX N/A
- IH N/A
- P/E Ratio
- VTYX N/A
- IH $9.64
- Revenue Growth
- VTYX N/A
- IH N/A
- 52 Week Low
- VTYX $0.78
- IH $1.52
- 52 Week High
- VTYX $10.47
- IH $3.60
- Technical
- Relative Strength Index (RSI)
- VTYX 74.09
- IH 44.96
- Support Level
- VTYX $8.90
- IH $2.66
- Resistance Level
- VTYX $10.02
- IH $2.88
- Average True Range (ATR)
- VTYX 0.78
- IH 0.16
- MACD
- VTYX -0.10
- IH -0.00
- Stochastic Oscillator
- VTYX 94.86
- IH 17.65
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.